Craig Hendrix is the Wellcome Professor and Director, Division of Clinical Pharmacology, at Johns Hopkins University School of Medicine. He trained in infectious diseases and clinical pharmacology at Hopkins before 10 years as an Air Force physician and 23 years at Johns Hopkins. Dr. Hendrix’s primary research focus is clinical pharmacology of HIV pre-exposure prophylaxis. He’s served as Principal Investigator of over 75 phase I clinical studies, mostly involving pre-exposure prophylaxis at Hopkins. He’s also served as principal pharmacologist for over 50 clinical trials in the Microbicide Trials Network and HIV Prevention Trials Network. He has published over 250 original scientific papers.
He greatly enjoys teaching and mentoring trainees at all levels and co-directs the Johns Hopkins T32 Clinical Pharmacology Training Program. He has received awards for teaching and mentoring from Johns Hopkins.
He has also served as member of a National Academy of Medicine Advisory Panel, the CDC Board of Scientific Counselors, the board of several pharmacology professional societies, current Chairman of the Board of the American Board of Clinical Pharmacology, and member of several FDA Advisory Committees. He has received awards for scientific achievement from the PhRMA Foundation, the American College of Clinical Pharmacology, the American Society of Clinical Pharmacology and Therapeutics, and the FDA.